PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28552457-3	2017	The objective of the present study is to investigate the direct effects of butylated hydroxyanisole on rat brain neurosteroidogenic 5alpha-reductase 1 (SRD5A1), 3alpha-hydroxysteroid dehydrogenase (AKR1C14), and retinol dehydrogenase 2 (RDH2).	Butylated Hydroxyanisole	75-99	steroid 5 alpha-reductase 1	Rattus norvegicus	152-158	
28552457-5	2017	Butylated hydroxyanisole inhibited SRD5A1, AKR1C14, and RDH2 with IC50 values of 4.731+-0.079muM, 5.753+-0.073muM, and over 100muM, respectively.	Butylated Hydroxyanisole	0-24	steroid 5 alpha-reductase 1	Rattus norvegicus	35-41	
28552457-6	2017	Butylated hydroxyanisole is a competitive inhibitor for both SRD5A1 and AKR1C14.	Butylated Hydroxyanisole	0-24	steroid 5 alpha-reductase 1	Rattus norvegicus	61-67	
28552457-8	2017	In conclusion, butylated hydroxyanisole is a potent inhibitor of SRD5A1 and AKR1C14, thus reducing the formation of active neurosteroids.	Butylated Hydroxyanisole	15-39	steroid 5 alpha-reductase 1	Rattus norvegicus	65-71	
27388148-10	2016	In conclusion, BHA directly inhibits the activities of CYP17A1 and HSD3B1, and the expression levels of Hsd17b3 and Srd5a1, leading to the lower production of androgen in Leydig cells.	Butylated Hydroxyanisole	15-18	steroid 5 alpha-reductase 1	Rattus norvegicus	116-122